Search Results - "pharmacodynamics"

Refine Results
  1. 1

    Pharmacodynamics for Medical Students by Lim, William/W.K.

    Published 2014
    “…A video primer on pharmacodynamics to enable medical students to understand the basic terminology and be able to interpret receptor binding and dose response...…”
    Get full text
    Get full text
  2. 2

    Pharmacodynamics and pharmacokinetics of phenylbutazone in calves by A.K., Arifah, Lees, P.

    Published 2002
    “…Phenylbutazone (PBZ) was administered to six calves intravenously (i.v.) and orally at a dose rate of 4.4 mg/kg in a three-period cross-over study incorporating a placebo treatment to establish its pharmacokinetic and pharmacodynamic properties. Extravascular distribution was determined by measuring penetration into tissue chamber fluid in the absence of stimulation (transudate) and after stimulation of chamber tissue with the mild irritant carrageenan (exudate). …”
    Get full text
    Get full text
  3. 3

    Ketoprofen in the Cat: Pharmacodynamics and Chiral Pharmacokinetics by Lees, Peter, Taylor, Polly Monroe, Landoni, Maria Fabiana, Abdul Kadir, Arifah, Waters, C.

    Published 2003
    “…The non-steroidal anti-inflammatory drug ketoprofen (KTP) was administered as the racemate to cats intravenously (IV) and orally at clinically recommended dose rates of 2 and 1 mg/kg, respectively, to establish its chiral pharmacokinetic and pharmacodynamic properties. After IV dosing, clearance was more than five times greater and elimination half-life and mean residence time were approximately three times shorter for R(−) KTP than for S(+) KTP. …”
    Get full text
    Get full text
  4. 4
  5. 5

    Pharmacodynamics and pharmacokinetics of ketoprofen enantiomers in sheep by Arifah, Abdul K., Landoni, Maria F., Frean, Stephen P., Lees, Peter

    Published 2001
    “…Objective - To establish pharmacokinetic and pharmacodynamic properties of a racemic mixture and individual R(-) and S(+) enantiomeric forms of ketoprofen (KTP) in sheep and determine pharmacodynamic variables of KTP by pharmacokinetic-pharmacodynamic modeling. …”
    Get full text
    Get full text
  6. 6

    Development of a Pharmacodynamic Model of Murine Malaria by Gibbons, Peter Luke

    Published 2015
    “…The rational design of antimalarial therapies has historically been compromised by a paucity of pharmacodynamic data contributing to resistance through deployment of suboptimal doses. …”
    Get full text
  7. 7
  8. 8
  9. 9

    Clinical pharmacokinetics and pharmacodynamics of mycophenolate in patients with autoimmune disease by Abd. Rahman, Nurul Azrin, Tett, Susan E., Staatz, Christian E.

    Published 2013
    “…An understanding of the pharmacokinetics and pharmacodynamics of mycophenolate in this population should assist the clinician with rational dosage decisions. …”
    Get full text
    Get full text
  10. 10
  11. 11
  12. 12
  13. 13

    Pharmacodynamics, chiral pharmacokinetics and PK–PD modelling of ketoprofen in the goat by Abdul Kadir, Arifah, Landoni, Maria Fabiana, Lees, Peter

    Published 2003
    “…The pharmacokinetics and pharmacodynamics of KTP were investigated using a tissue cage model of acute inflammation. …”
    Get full text
    Get full text
  14. 14

    Pharmacodynamics, chiral pharmacokinetics and PK-PD modelling of ketoprofen in the goat by A. K., Arifah, M. F., Landoni, P., Lees

    Published 2003
    “…The pharmacokinetics and pharmacodynamics of KTP were investigated using a tissue cage model of acute inflammation. …”
    Get full text
    Get full text
  15. 15

    Mechanism-based model of parasite growth and dihydroartemisinin pharmacodynamics in murine malaria by Patel, K., Batty, Kevin, Moore, Brioni, Gibbons, P., Bulitta, J., Kirkpatrick, C.

    Published 2013
    “…Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) models for antimalarials are scarce, despite their potential to optimize antimalarial combination therapy. …”
    Get full text
  16. 16

    Pharmacokinetics, Pharmacodynamics and Allometric Scaling of Chloroquine in a Murine Malaria Model by Moore, Brioni, Page-Sharp, Madhu, Stoney, Jillian, Ilett, K., Jago, Jeffrey, Batty, Kevin

    Published 2011
    “…The single-dose pharmacodynamic study (10 to 50 mg CQ/kg of body weight) showed dose-related reduction in parasitemia (5- to >500-fold) and a nadir 2 days after the dose. …”
    Get full text
  17. 17
  18. 18
  19. 19
  20. 20

    Applying pharmacokinetic/pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development by Abdul Aziz, Mohd. Hafiz, Lipman, Jeffrey, Mouton, Johan W., Hope, William W., Roberts, Jason A.

    Published 2015
    “…Optimal and timely pharmacokinetic/pharmacodynamic (PK/PD) target attainment has been associated with an increased likelihood of clinical andmicrobiological success in critically ill patients. …”
    Get full text
    Get full text